[From Medicalxpress, Feb 22, 2016] The antiretroviral (ARV) drug atazanavir—sometimes included in treatments to prevent mother-to-child HIV transmission during pregnancy—may have small but significant effects on infant development, reports a study in the journal AIDS. For more, click here.
[From CFJC Today, Feb 19, 2016] Vancouver- British Columbia health officials are considering offering supervised-injection services in community health clinics, triggered by a new federal government and a spike in fentanyl overdoses. For more, click here.
Vancouver and Victoria consider supervised injection in health centres Read More »
[From Metro News, Feb 17, 2016] Everyday cholesterol-lowering drugs may be able to slow the accelerated aging of people with HIV, according to new research from the University of Alberta. Thanks to antiretroviral therapy, an HIV diagnosis is no longer a death sentence. But people with HIV do have much higher levels of inflammation in
Common drug may slow accelerated aging of HIV:U of A study Read More »
[From BC Women’s Hospital] In conjunction with the BC Centre for Excellence in HIV/AIDS, the Oak Tree Clinic has developed clinical guidelines for the treatment of HIV-positive women during labour and delivery and infants born to HIV-positive women. To access the HIV/AIDS Clinical Guidelines, click here.
HIV/AIDS Clinical Guidelines Read More »
[From Medscape, Feb 5, 2016] Tenofovir resistance is higher than expected in adult patients with HIV and treatment failure, according to a global evaluation published online January 28 in Lancet Infectious Disease. The higher-than-expected rates were particularly pronounced in low- to middle-income countries. For more, click here.
HIV: Tenofovir Resistance Higher Than Expected Read More »
